Chong Kun Dang Holdings Corp.
001630.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$177.33B
Close$
Share Statistics
| Market cap | $177.33 Billion |
|---|---|
| Enterprise Value | $739.29 Billion |
| Dividend Yield | $1400.00 (3.76%) |
| Earnings per Share | $8492.65 |
| Beta | 0.53 |
| Outstanding Shares | 4,761,000 |
Return
| Return on Equity | 8.18% |
|---|---|
| Return on Assets | 3.07% |
| Return on Invested Capital | -3.64% |
Valuation & Multiples
| P/E Ratio | 2.73 |
|---|---|
| PEG | 4.59 |
| Price to Sales | 0.18 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | 0.77 |
| Enterprise Value to EBIT | -18.71 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.82 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$134.40 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chong Kun Dang Holdings Corp.
38 employees
CEO: Hee-Nam Choi Based in Seoul, South Korea, Chong Kun Dang Holdings Corp. has manufactured and supplied pharmaceutical goods since its inception in 1941, reaching both South Korean and global markets.